We are live on
!
Find out more
FGP
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter
Est. Return
+0.81%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$14.2B
AUM Growth
+$326M
(+2.4%)
Cap. Flow
+$206M
Cap. Flow
% of AUM
1.46%
Top 10 Holdings %
Top 10 Hldgs %
19%
Holding
1,229
New
515
Increased
214
Reduced
228
Closed
267
Avg Time Held Equity + Options
1.1
quarters
Top 10 Avg Time Held Equity + Options
0.6
quarters
Top 20 Avg Time Held Equity + Options
0.4
quarters
Avg Time Held Equity only
1.1
quarters
Top 10 Avg Time Held Equity only
0.6
quarters
Top 20 Avg Time Held Equity only
0.4
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$134M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$120M |
| 3 |
KKR & Co
KKR
|
+$113M |
| 4 |
Mondelez International
MDLZ
|
+$103M |
| 5 |
AXIS Capital
AXS
|
+$97.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$303M |
| 2 |
Boston Scientific
BSX
|
+$127M |
| 3 |
Lennar Class A
LEN
|
+$95.9M |
| 4 |
Martin Marietta Materials
MLM
|
+$94.6M |
| 5 |
Colgate-Palmolive
CL
|
+$92M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.98% |
| 2 | Technology | 14.39% |
| 3 | Miscellaneous | 12.72% |
| 4 | Industrials | 12.27% |
| 5 | Healthcare | 11.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Globe Life
GL
$12.8B
| $38.1M | 0.27% |
273,565
+58,442
| +27% | +$8.25M |
2024 Q4
5 quarters
|
|
127
Lumentum
LITE
$89.2B
| $38M | 0.27% |
54,076
-55,860
| -51% | -$30.7M |
2025 Q1
4 quarters
|
|
128
Chubb
CB
$134B
| $37.9M | 0.27% |
+116,143
| New | +$37.3M |
2026 Q1
0 quarters
|
|
129
PNC Financial Services
PNC
$88.1B
| $37.6M | 0.27% |
180,790
-114,845
| -39% | -$25M |
2025 Q4
1 quarter
|
|
130
Home Depot
HD
$290B
| $37.4M | 0.26% |
113,602
+32,848
| +41% | +$12M |
2024 Q4
5 quarters
|
|
131
Toro Company
TTC
$9.2B
| $36.7M | 0.26% |
392,494
-198,327
| -34% | -$18.7M |
2025 Q1
4 quarters
|
|
132
Brixmor Property Group
BRX
$8.4B
| $36.4M | 0.26% |
1,263,289
+309,094
| +32% | +$8.73M |
2025 Q4
1 quarter
|
|
133
DELISTED
AvalonBay Communities
AVB
| $36.2M | 0.26% |
+221,344
| New | +$38.7M |
2026 Q1
0 quarters
|
|
134
Hilton Worldwide
HLT
$74B
| $35.8M | 0.25% |
117,688
+45,712
| +64% | +$13.9M |
2025 Q4
1 quarter
|
|
135
Teleflex
TFX
$5.37B
| $35.5M | 0.25% |
296,487
+95,548
| +48% | +$10.5M |
2024 Q4
5 quarters
|
|
136
Spotify
SPOT
$109B
| $35.4M | 0.25% |
73,005
+6,989
| +11% | +$3.51M |
2025 Q4
1 quarter
|
|
137
UWM Holdings
UWMC
$355M
| $35.3M | 0.25% |
+9,759,126
| New | +$44.9M |
2026 Q1
0 quarters
|
|
138
Texas Capital Bancshares
TCBI
$3.95B
| $35.3M | 0.25% |
+371,595
| New | +$36.2M |
2026 Q1
0 quarters
|
|
139
Coherent
COHR
$56.1B
| $34.9M | 0.25% |
146,578
-114,265
| -44% | -$26.2M |
2024 Q4
5 quarters
|
|
140
IQVIA
IQV
$43.1B
| $34.8M | 0.25% |
+203,851
| New | +$39.8M |
2026 Q1
0 quarters
|
|
141
Cummins
CMI
$73.1B
| $34.7M | 0.25% |
64,581
-19,943
| -24% | -$11.3M |
2025 Q3
2 quarters
|
|
142
State Street
STT
$48.1B
| $34.4M | 0.24% |
271,468
-105,966
| -28% | -$13.6M |
2025 Q1
4 quarters
|
|
143
BioMarin Pharmaceuticals
BMRN
$10.8B
| $34.2M | 0.24% |
606,187
+114,285
| +23% | +$6.66M |
2025 Q2
3 quarters
|
|
144
Fabrinet
FN
$16.1B
| $34.1M | 0.24% |
+65,329
| New | +$33.2M |
2026 Q1
0 quarters
|
|
145
Carlyle Group
CG
$13.7B
| $33.5M | 0.24% |
693,262
+249,120
| +56% | +$13.7M |
2025 Q4
1 quarter
|
|
146
Option Care Health
OPCH
$4.66B
| $33.4M | 0.24% |
1,239,573
+323,675
| +35% | +$10.5M |
2025 Q4
1 quarter
|
|
147
Supernus Pharmaceuticals
SUPN
$2.49B
| $33.1M | 0.23% |
641,319
+445,001
| +227% | +$22.7M |
2025 Q4
1 quarter
|
|
148
Synopsys
SNPS
$96.5B
| $33.1M | 0.23% |
83,524
+80,193
| +2,407% | +$36.3M |
2025 Q4
1 quarter
|
|
149
BOK Financial
BOKF
$7.67B
| $32.9M | 0.23% |
257,045
-238,487
| -48% | -$30.6M |
2024 Q4
5 quarters
|
|
150
WESCO International
WCC
$17.8B
| $32.7M | 0.23% |
+119,400
| New | +$33.5M |
2026 Q1
0 quarters
|
|
Similar funds
ECM
MIFH
GF
AIM
OTPPB
AA
IWC
Freestone Grove Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Freestone Grove Partners held 1,229 positions worth $14.2B, up 2.4% from $13.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Freestone Grove Partners's Q1 2026 filing shows 515 new, 214 increased, 228 reduced and 267 closed positions. Its largest new stake was Citigroup: 1,180,436 shares worth $134M. The largest sale was iShares Core S&P 500 ETF, an estimated $303M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Miscellaneous.
- Freestone Grove Partners's largest Q1 2026 buy was Citigroup: 1,180,436 shares worth $134M.
- Freestone Grove Partners added most to AXIS Capital in Q1 2026, an estimated $97.1M increase.
- Freestone Grove Partners's biggest Q1 2026 reduction was iShares Core S&P 500 ETF, cutting an estimated $303M.
- Freestone Grove Partners fully exited Boston Scientific in Q1 2026, selling an estimated $127M.
- Freestone Grove Partners's ten largest holdings make up 19% of its $14.2B portfolio in Q1 2026.
- Freestone Grove Partners opened 515 new positions and closed 267 in Q1 2026.
- Freestone Grove Partners's portfolio value rose 2.4% quarter-over-quarter to $14.2B.
Based on Freestone Grove Partners's 13F filing for Q1 2026, filed 15 May 2026.